**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 83-40-9 |3-Methylsalicylic acid | 99 | 201-473-8 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 22 41
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. Risk of serious damage to eyes.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
Harmful if swallowed.
Inhalation:
May cause respiratory tract irritation.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If breathing is difficult, give oxygen. Do NOT use
mouth-to-mouth resuscitation. If breathing has ceased apply
artificial respiration using oxygen and a suitable mechanical device
such as a bag and a mask.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. In case of fire, use
carbon dioxide, dry chemical powder or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Avoid generating dusty conditions. Provide
ventilation. Cover with dry earth, dry sand, or other non-combustible
material followed with plastic sheet to minimize spreading and
contact with water.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use only in a well-ventilated area. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 83-40-9:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: White - Pale Pink Powder
Odor: Odorless
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 163.00 - 165.00 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Partially soluble.
Specific Gravity/Density:
Molecular Formula: C8H8O3
Molecular Weight: 152.15
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Volatile in steam.
Conditions to Avoid:
Incompatible materials, dust generation, strong oxidants, steam.
Incompatibilities with Other Materials:
Acid chlorides, acid anhydrides, strong bases, strong oxidizing
agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 83-40-9: GP3920000
LD50/LC50:
CAS# 83-40-9: Oral, mouse: LD50 = 1 gm/kg; Oral, rat: LD50 = 445
mg/kg.
Carcinogenicity:
3-Methylsalicylic acid -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
R 41 Risk of serious damage to eyes.
Safety Phrases:
S 22 Do not breathe dust.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
WGK (Water Danger/Protection)
CAS# 83-40-9: 1
Canada
CAS# 83-40-9 is listed on Canada's NDSL List.
CAS# 83-40-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 83-40-9 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 11/23/1998 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
3-Methyl-5-Methoxycarbonyl-1-Benzyl-4-Piperidone Hydrochloride, 99%
| 0-01-1 |
|
4-Decanol, 99%
| 2051-31-2 |
|
5-Chloro-1,3-dimethoxybenzene, 97+%
| 7051-16-3 |
|
Bis-(Benzonitrile)-Palladium(II)Chloride, 99+%
| 14220-64-5 |
|
N-(1-Anilinonaphthyl-4)-Maleimide
| 50539-45-2 |
|
4-Chloro-O-Anisic Acid, 99%
| 57479-70-6 |
|
Furfuryl Mercaptan, 97%
| 98-02-2 |
|
4-Methoxybenzenethiol, 98%
| 696-63-9 |
|
6-Dimethylaminopurine
| 938-55-6 |
|
2-Amino-4,6-Dichloropyrimidine, Tech.
| 56-05-3 |
|
2,4-Dihydroxy-n-(2-Hydroxyethyl)benzamide, 99% (TLC)
| 24207-41-8 |
|
Brucine dihydrate, 99%
| 145428-94-0 |
|
2-Indanol, 99%
| 4254-29-9 |
|
Trifluoroacetic Acid, Ammonium Salt, 98%
| 3336-58-1 |
|
10-Methylphenothiazine
| 1207-72-3 |
|
Trimethyl Phosphate, P.A.
| 512-56-1 |
|
4-Bromotoluene, 99%
| 106-38-7 |
|
Ethylenediaminetetraacetic Acid Copper, Disodium Salt Dihydrate, 98%
| 61916-40-3 |
|
3-Methylsalicylic acid, 99%
| 83-40-9 |
|
5-Benzyloxytryptamine hydrochloride, 98%
| 52055-23-9 |
|
3-Formylsalicylic acid, 97%
| 610-04-8 |
|
3-Methylcyclopentanol, 99%, mixture of isomers
| 18729-48-1 |
|
L(-)-Dibenzoyl-L-tartaric acid monohydrate , 98%
| 2743-38-6 |
|
1-Phenoxy-2-propanol,97%
| 770-35-4 |
|
Ethyl 2(2-Aminothiazole-4-yl)-2-Methoxyiminoacetate, 98%
| 64485-88-7 |
|
Borane-tetrahydrofuran complex, 1M solution in tetrahydrofuran
| 109-99-9 |
|
N-Phenyl-P-Phenylenediamine Monohydro-Chloride, 99% (Titr.)
| 2198-59-6 |
|
Dipentaerythritol, 90%
| 126-58-9 |
|
2,4'-Dipyridyl, 97+%
| 581-47-5 |
|
N,N-Bis(2-Cyanoethyl)Formamide
| 3445-84-9 |
|
L-(+)-Lysine Monohydrate 99%
| 39665-12-8 |
|
Albizziin, 98%
| 1483-07-4 |
|
2-Methyltetrahydrofuran-3-one, 98%
| 3188-00-9 |
|
N-Acryloyltris(Hydroxymethyl)aminomethane (Nat)
| 13880-05-2 |
|
Sulforhodamine 101 (Free Acid), Laser Grade, 99% (UV-Vis)
| 82354-19-6 |
|
Progesterone, 98%
| 57-83-0 |
|
5-Bromo-2-Fluorobenzaldehyde, 98%
| 93777-26-5 |
|
5-Amino-3-Methylisothiazole Hydrochloride
| 52547-00-9 |
|
Pentafluoropropionic Anhydride
| 356-42-3 |
|
Albumine bovine serum,additional reagent for igss, protease free
| |
|
D-(+)-Methioninol
| 87206-44-8 |
|
alpha-Chloro-o-xylene, 99%
| 552-45-4 |
|
2-(5-Bromo-2-Pyridylazo)-5- (Diethylamino)Phenol, 99+% (Titr.)
| 14337-53-2 |
|
(S)-(+)-alpha-Methoxy-alpha-trifluoro-methylphenylacetyl chloride,
| 20445-33-4 |
|
(1S,2S,3R,5S)-(+)-2,3-Pinanediol, 98%
| 18680-27-8 |
|
Molecular Sieves, 3A, 8 to 12 Mesh
| 308080-99-1 |
|
1-Methyl-4-piperidone, 98%
| 1445-73-4 |
|
2-Amino-6,7-Dimethyl-4-Hydroxypteridine
| 611-55-2 |
|
Dinonyl Phthalate
| 84-76-4 |
|
Phenyl sulfoxide, 97%
| 945-51-7 |
|
|